Patients who present for the first time to Emergency Room with renal colic due to a distal ureteral calculus (as diagnosed with spiral CT scan and KUB) will be randomized to receive Xatral 10mg po once a day or placebo once discharged from the ER. The purpose of this study is to assess if patients treated with Xatral will have a higher spontaneous passage rate of their ureteral stone than those treated with placebo.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
10 mg PO once a day
10 mg PO once a day
St. Michael's Hospital
Toronto, Ontario, Canada
The primary outcome will be Cox proportional hazards survival analysis of stone passage over time
Time frame: 4 weeks
Secondary outcomes will be stone passage rates, pain scores, intervention rates, hospitalization rates and complication rates
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.